Think Biosolution is a digital health technology provider with multiple remote patient monitoring devices and platforms. These platforms are privately labeled and added to their current platforms by digital health enterprises in the USA and the E.U. The Remote Patient Monitoring (RPM) platforms include the wearable QuasaR™ device, App for patients and next-of-kin, HIPAA compliant cloud, EMR compatible dashboard for physicians, and REST APIs for integration. Think Biosolution has developed fifteen remote patient monitoring platforms which include at-home stress monitoring, at-home geriatric care, at-home post-hospitalization care, at-home cardiac care, at-home respiratory care, etc. covers almost all aspects of at-home chronic care.
Think Biosolution’s mission is to combine AI and data visualization with medical devices to deliver the best-in-class patient-centric at-home chronic care. The company was set up in March 2016 in Dublin, Ireland, to productize a patented optical sensor technology. Think Biosolution built its first fully functioning QuasaR™ prototype device in October 2017. The company then got a further US$350,000 investment from Luminate, the world’s largest Optics Accelerator, in July 2018 to scale this early stage prototypes to a manufacturing-ready product. At present, Think Biosolution is projected to secure three FDA 510(K) clearances for the QuasaR™ device and two RPM platforms by Q2 2020 and go to market by Q3 2020.
Architect of A Successful Roadmap
Shourjya Sanyal, the CEO of Think Biosolution, is a Forbes correspondent in AI and Healthcare, a TEDx speaker, a Regional Partner of Faster Capital, and Lecturer in Data Science in Digital Skills Global (affiliated to Boston College). He is also a part of the Roster of Experts, Digital Health Technical Advisory Board, World Health Organization (2019), and Standard Committee Member for Remote Patient Monitoring Standard, CHQI. Shourjya holds a Ph.D. in theoretical physics and is a serial entrepreneur with a passion for developing and commercializing cutting-edge technology.
Shourjya and his co-founder Koushik who serves as the CTO, designed the patented optical technology used in the QuasaR™ device. Shourjya was also the key architect behind developing the fifteen at-home chronic care platforms. He is currently working on building a unified patient journey roadmap as an enterprise solution for digital health, health insurance, and government enterprises.
Delivering Personalized Healthcare with AI
Think Biosolution’s remote patient monitoring dashboards use smart data visualization (a key part in delivering Artificial Intelligence) to help patients, next-of-kin, nurses and physicians visualize customized information that is most relevant to them in delivering care.
Artificial Intelligence (AI) is also embedded in the QuasaR™ device, App, and EMR Dashboard. For example, in the at-home geriatric care platform, the QuasaR™ device use can act as a virtual nurse by giving daily personalized medication reminders. The device also uses AI to detect the cause of fall in real-time and significantly improves outcomes of emergency care.
AI-Enabled Smart Digital Technologies Assisting Life
AI is one of the most significant disruptive forces in the healthcare industry, affecting all aspects of care delivery. Shourjya personally believes the biggest impact of AI will be in the remote patient monitoring sector, which will fundamentally displace the center of care from hospital-based acute care to a patient’s home. Where community nurses and next-of-kin will be able to monitor patients and deliver chronic care long before the onset of acute conditions.
Some other digital health technologies such as smart devices assisted daily living, smart device assisted fall detection, AI aided diagnostics, AI aided operating robots, and AI aided CT-imaging are also examples of how artificial intelligence will impact healthcare.
Innovation at the Core of Business Processes
Innovation is at the heart of Think Biosolution. The QuasaR™ device is the most accurate optical biometric sensor in its class. This allows Think Biosolution to build the most sophisticated care pathways for the healthcare industry. The company can also use AI to qualitatively access the financial impact of each of its care-pathways for the payers, hospitals, RPM service providers, next-of-kin, and patients. Think Biosolution’s final product is an AI-powered unified patient journey roadmap as an enterprise solution for digital health, health insurance, and government enterprises.
Think Biosolution innovation is also a key part of their business processes. The company’s partnership uses a unique three-step process that allows easy integration of its platform with the partners’ existing infrastructure. The company also helps partners identify and monitor KPIs to measure the impact of RPM on their business.
Think Biosolution was announced as one of the four winners of Luminate in July 2018, the world’s largest Optics Accelerator. The company was also named one of Europe’s top 20 Health and Medtech start-ups by the Silicon Republic in January 2018. It also won the Irish Startup Laboratory of the Year 2018 award.
Think Biosolution’s QuasaR™ device and platform has been fully built and tested with potential partners including the European Space Agency, Health Innovation Hub Ireland, Royal College of Surgeons Ireland, and University of Rochester Medical Centre. The company has also procured letters of intent worth US$15 million from eight digital health enterprises in the US.
Think Biosolution’s biggest challenge is to get the regulatory clearance for all their QuasaR™ devices and platforms. Given the innovativeness of the product, the company is working closely with both FDA in the US and CE in Europe to ensure that their medical devices and platforms match the best in class safety, accuracy, and good manufacturing practices.
The Future of AI-Powered Healthcare
AI in healthcare is still like what the internet used to be in the 1990s. Clinicians’ use of EMRs is just scratching the surface of digital healthcare. Shourjya believes in the next twenty years AI combined with smart wearable medical devices, will enable the delivery of care before the onset of chronic or acute conditions. Also, patients, their next-of-kin, and nurse practitioners will be included in delivering care pathways.